Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

A recombinant live attenuated tetravalent dengue vaccine (CYD-TDV) has been shown to be efficacious in preventing virologically-confirmed dengue disease, severe dengue disease and dengue hospitalization in children aged 2–16 years in Asia and Latin America. We analyzed pooled safety data from 18 pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gailhardou, Sophia, Skipetrova, Anna, Dayan, Gustavo H., Jezorwski, John, Saville, Melanie, Van der Vliet, Diane, Wartel, T. Anh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945086/
https://www.ncbi.nlm.nih.gov/pubmed/27414655
http://dx.doi.org/10.1371/journal.pntd.0004821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945086/
https://www.ncbi.nlm.nih.gov/pubmed/27414655
http://dx.doi.org/10.1371/journal.pntd.0004821

Ejemplares similares